Temporal Analysis of Amylase Expression in Control, Autoantibody-Positive, and Type 1 Diabetes Pancreatic Tissues

被引:20
|
作者
Kusmartseva, Irina [1 ]
Beery, Maria [1 ]
Hiller, Helmut [1 ]
Padilla, Myriam [1 ]
Selman, Stephen [1 ]
Posgai, Amanda [1 ]
Nick, Harry S. [2 ]
Campbell-Thompson, Martha [1 ]
Schatz, Desmond A. [3 ]
Haller, Michael J. [3 ]
Wasserfall, Clive H. [1 ]
Atkinson, Mark A. [1 ,3 ]
机构
[1] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA
[2] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA
基金
美国国家卫生研究院;
关键词
SECRETION; INSULIN;
D O I
10.2337/db19-0554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Within the human pancreas, exocrine and endocrine cells control secretion of digestive enzymes and production of hormones to maintain metabolic homeostasis, respectively. While the vast majority of type 1 diabetes research efforts have focused on endocrine function and autoimmunity, recent studies identified a series of unique features (e.g., reduced weight and volume, increased density of leukocytes) within the exocrine pancreas in this disease, but the mechanisms underlying these aberrancies are unknown. Therefore, we histologically assessed amylase, insulin, glucagon, lipase, and/or trypsinogen in 78 organ donor pancreata from birth through adulthood in control subjects and those at various stages of type 1 diabetes. While amylase-positive (AMY(+)) acinar cells were detectable in pancreata from all study groups, tissues from individuals >2 years of age contained clusters of acinar cells devoid of amylase (AMY(-)). A majority of these AMY(-) cell clusters localized proximal to islets (i.e., peri-islet). Additionally, most AMY(-) clusters were positive for the exocrine enzymes lipase and trypsinogen. Interestingly, type 1 diabetes pancreata displayed significant reductions in the frequency of these AMY(-) cell clusters. These results support a contribution of the islet-acinar axis in pancreatic development and underscore a potential role for the exocrine pancreas in the pathogenesis of type 1 diabetes.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 50 条
  • [1] Increase in Pancreatic Proinsulin and Preservation of -Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset
    Rodriguez-Calvo, Teresa
    Zapardiel-Gonzalo, Jose
    Amirian, Natalie
    Castillo, Ericka
    Lajevardi, Yasaman
    Krogvold, Lars
    Dahl-Jorgensen, Knut
    von Herrath, Matthias G.
    DIABETES, 2017, 66 (05) : 1334 - 1345
  • [2] Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus
    Jackson, Jessica
    Posgai, Amanda
    Campbell-Thompson, Martha
    Kusmartseva, Irina
    DIABETES CARE, 2017, 40 (05) : 723 - 725
  • [3] A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type-1
    Sosenko, Jay M.
    Krisher, Jeffrey P.
    Palmer, Jerry P.
    Mahon, Jeffrey
    Cowie, Catherine
    Greenbaum, Carla J.
    Cuthbertson, David
    Lachin, John M.
    Skyler, Jay S.
    DIABETES CARE, 2008, 31 (03) : 528 - 533
  • [4] Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children
    P. Achenbach
    M. Hummel
    L. Thümer
    H. Boerschmann
    D. Höfelmann
    A. G. Ziegler
    Diabetologia, 2013, 56 : 1615 - 1622
  • [5] Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children
    Lamichhane, Santosh
    Sen, Partho
    Dickens, Alex M.
    Krakstrom, Matilda
    Ilonen, Jorma
    Lempainen, Johanna
    Hyoty, Heikki
    Lahesmaa, Riitta
    Veijola, Riitta
    Toppari, Jorma
    Hyotylainen, Tuulia
    Knip, Mikael
    Oresic, Matej
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [6] A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History
    Sosenko, Jay M.
    Skyler, Jay S.
    DiMeglio, Linda A.
    Beam, Craig A.
    Krischer, Jeffrey P.
    Greenbaum, Carla J.
    Boulware, David
    Rafkin, Lisa E.
    Matheson, Della
    Herold, Kevan C.
    Mahon, Jeffrey
    Palmer, Jerry P.
    DIABETES CARE, 2015, 38 (02) : 271 - 276
  • [7] Population-Based Optimization of Metabolic Monitoring for Autoantibody-Positive Individuals at Risk for Type 1 Diabetes
    Orourke, Colin
    Speake, Cate
    Ylescupidez, Alyssa
    Bender, Christine
    Lord, Sandra
    DIABETES, 2022, 71
  • [8] Characterization of regulatory T cells in patients with type 1 diabetes and autoantibody-positive at-risk subjects
    Gazali, Ahmad Mahfuz
    Viisanen, Tyyne
    Ihantola, Emmi-Leena
    Nanto-Salonen, Kirsti
    Veijola, Riitta
    Toppari, Jorma
    Knip, Mikael
    Ilonen, Jorma
    Kinnunen, Tuure
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2016, 83 (05) : 368 - 368
  • [9] Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children
    Achenbach, P.
    Hummel, M.
    Thuemer, L.
    Boerschmann, H.
    Hoefelmann, D.
    Ziegler, A. G.
    DIABETOLOGIA, 2013, 56 (07) : 1615 - 1622
  • [10] A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts
    Sosenko, Jay M.
    Cuthbertson, David
    Jacobsen, Laura M.
    Redondo, Maria J.
    Sims, Emily K.
    Ismail, Heba M.
    Herold, Kevan C.
    Skyler, Jay S.
    Nathan, Brandon M.
    DPT TrialNet Study Groups
    DIABETES TECHNOLOGY & THERAPEUTICS, 2025,